The DDA is reiterating advice that dispensing practices should not commit to buying Falsified Medicines Directive (FMD) software until NHS England has finalised funding available from GP IT Futures.
In his presentation to the DDA 2018 conference, Claymore Richardson, senior policy manager: pharmacy, Department of Health and Social Care said that NHS England was “well aware that the FMD is necessary for GPs to fulfil NHS contract” and that conversations over central funding had started. But he said: “This will take some time to implement.”
In his presentation, Mr Richardson also revealed that some European member states have exempted GPs from the FMD decommissioning process. He said that as a result, the Department of Health and Social Care would examine its current position for England’s GPs using the FMD.
He said there was constructive discussion with the DDA to achieve a sensible approach to implementation, although he admitted that full FMD dispensing could be as far as five years away. He said: “There is a long tail in transition.” He could not say when firm implementation guidance would be available, but said that dispensers can sign up for end-user registration via the SecurMed UK Registration Portal.
He reminded delegates that FMD compliance is a regulatory obligation, and that genuine non-compliance could result in criminal sanctions.” Dispensaries need to have a plan in place that shows willingness to comply with the FMD.”
Read the BMA view on the FMD
Read the full presentation from Claymore Richardson
Read the related presentation from Takeda